TopicNeuroscience
Content Overview
5Total items
5Seminars

Latest

SeminarNeuroscience

Studying genetic overlap between ASD risk and related traits: From polygenic pleiotropy to disorder-specific profiles

Beate St Pourcain
Max Planck Institute for Psycholinguistics
Jun 15, 2022
SeminarNeuroscienceRecording

Post-traumatic headache

David Dodick
Department of Neurology, Mayo Clinic, Scottsdale Arizona, USA
Feb 24, 2022

Concussion (mild traumatic brain injury) affects approximately 50 million people annually. Headache is the most common symptom after concussion and persists in up to 50% of those affected for at least one-year. The biological underpinnings of and the efficacy and tolerability of treatments for post-traumatic headache has historically received little attention. While treatment in clinical practice is mostly directly at the underlying phenotype of the headache, persistent post-traumatic headache is considered to be less responsive to treatments used to treat migraine or tension-type headache. Over the past several years, significant pre-clinical research has begun to elucidate the mechanism(s) involved in the development of post-traumatic headache, and a concerted effort to evaluate the efficacy of selected treatments for persistent post-traumatic headache has begun. This presentation will review the epidemiology, pathophysiology, and emerging data on the prevention and treatment of post-traumatic headache.

SeminarNeuroscience

Investigating the environmental etiology of autism spectrum disorder

Magdalena Janecka
Icahn School of Medicine at Mount Sinai
Jun 9, 2021
SeminarNeuroscience

The early impact of COVID-19 on mental health and community physical health services and their patients’ mortality in Cambridgeshire and Peterborough, UK

Rudolf Cardinal
Department of Psychiatry, University of Cambridge
Nov 10, 2020

COVID -19 has affected social interaction and healthcare worldwide. This talk will focus on the impact of the pandemic and “lockdown” on mental health services, community physical health services, and patient mortality in Cambridgeshire and Peterborough, based on the analysis of de-identified data from the primary NHS provider of secondary care mental health services to this population (~0.86 million)

SeminarNeuroscienceRecording

NeuroCOVID: Epidemiology, biomarkers, and pathophysiology

David Menon
Department of Anaethesia, University of Cambridge
Oct 20, 2020

epidemiology coverage

5 items

Seminar5

Share your knowledge

Know something about epidemiology? Help the community by contributing seminars, talks, or research.

Contribute content
Domain spotlight

Explore how epidemiology research is advancing inside Neuroscience.

Visit domain

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.